Abstract:Abstract The randomized play-the winner (RPW) rule is very useful in clinical trials for patient allocation with two treatments. Wei (1979) introduces the generalized Friedman’s urn (GFU) model to clinical trials of K treatment (as an extension of the RPW). In this paper, we consider a general kind of adaptive designs, whose generations depend on an estimated parameter, for example the estimated success rate. Using this kind of adaptive designs, more informations of previous stages are used to update the model at each stage, and more patients may be assigned to a better treatment than the RPW rule and Wei’s rule. The strong consistency and the asymptotic normalities are established for both the urn composition and the number of patients assigned to each treatment. A adaptive design proposed by Bai, Hu and Shen (2001) recently is a simple special example. 1 Introduction and main results 1.1 Introduction and the Model In comparing of K treatments, suppose that patients are available for the study sequentially and must be assigned to a treatment group immediately upon arrival. Adaptive designs, which use accumulating information to assign patients to treatments, tend to assign more patients to better treatments in clinical trials. A typical probability model for adaptive clinical trials is the Generalized Friedman’s Urn (GFU) model (also named as Generalized P´olya Urn (GPU) in literature). The model is described as follows. Consider an urn containing particles of K types, respectively representing K ’treatments’ in a clinical trial. The patients are to be allocated sequentially to the treatments. At the beginning, the urn contains Y0 = (Y0;1;:::;Y0;K) particles, where Y0;k > 0 denotes the number of particles of type k, k = 1;:::;K. At stage i, i = 1;2;:::, a particle is drawn from the urn and replaced. If the particle is of type k, then the treatment k is assigned to the i-th patient, k = 1;:::;K, i = 1;2;:::. After observing a random variables »i;k which may be considered as the response of the i-th patient on the treatment k, an additional Di(k;q;»i;k) particles of type q,

A response‐adaptive randomization procedure for multi‐armed clinical trials with normally distributed outcomes

Nonparametric Response-Adaptive Randomization for Continuous Responses

A Bayesian Response-Adaptive Covariate-Balanced Randomization Design with Application to A Leukemia Clinical Trial

Bayesian adaptive bandit-based designs using the Gittins index for multi-armed trials with normally distributed endpoints

Response adaptive randomization procedures in seamless phase II/III clinical trials.

Response‐Adaptive Randomization Procedure in Clinical Trials with Surrogate Endpoints

Bayesian response adaptive randomization design with a composite endpoint of mortality and morbidity

Efficient Randomized-Adaptive Designs

A Novel Statistical Test for Treatment Differences in Clinical Trials using a Response Adaptive Forward Looking Gittins Index Rule

Group Response-Adaptive Randomization With Delayed and Missing Responses

A two armed optimal response adaptive randomization for ordinal categorical responses with possible misclassification

Comparison of response adaptive randomization features in multiarm clinical trials with control

Bayesian Response Adaptive Randomization for Randomized Clinical Trials With Continuous Outcomes: The Role of Covariate Adjustment

Statistical Inference of Adaptive Randomized Clinical Trials for Personalized Medicine

Sequential monitoring of response-adaptive randomized clinical trials

Implementing Response-Adaptive Randomisation in Stratified Rare-disease Trials: Design Challenges and Practical Solutions

Approximation to the optimal allocation for response adaptive designs

The asymptotic theorems of adaptive designs for clinical trials with generations depending on the estimated success rates

A Markov decision process for response-adaptive randomization in clinical trials

A Bayesian Group Sequential Design for Randomized Biosimilar Clinical Trials with Adaptive Information Borrowing from Historical Data

Asymptotically best response-adaptive randomization procedures☆